Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 379

1.

Shifting the HIV Paradigm from Care to Cure: Proceedings from the Caribbean Expert Summit in Barbados, August 2017.

Landis RC, Abayomi EA, Bain BC, Greene E, Janossy G, Joseph P, Kerrigan D, McCoy JP, Nunez C, O'Gorman M, Pastoors A, Parekh BS, Quimby KR, Quinn TC, Robertson KR, Thomas R, van Gorp E, Vermund SH, Wilson V.

AIDS Res Hum Retroviruses. 2018 Jul;34(7):561-569. doi: 10.1089/AID.2017.0310. Epub 2018 Jun 5.

2.

No effect of a pulsed magnetic field on induced ischemic muscle pain. A double-blind, randomized, placebo-controlled trial.

Szemerszky R, Szabolcs Z, Bogdány T, Jánossy G, Thuróczy G, Köteles F.

Physiol Behav. 2018 Feb 1;184:55-59. doi: 10.1016/j.physbeh.2017.11.005. Epub 2017 Nov 7.

PMID:
29127072
3.

Extremely low frequency (ELF) stray magnetic fields of laboratory equipment: a possible co-exposure conducting experiments on cell cultures.

Gresits I, Necz PP, Jánossy G, Thuróczy G.

Electromagn Biol Med. 2015 Sep;34(3):244-50. doi: 10.3109/15368378.2015.1076440.

PMID:
26444200
4.

DNA integrity of human leukocytes after magnetic resonance imaging.

Szerencsi Á, Kubinyi G, Váliczkó É, Juhász P, Rudas G, Mester Á, Jánossy G, Bakos J, Thuróczy G.

Int J Radiat Biol. 2013 Oct;89(10):870-6. doi: 10.3109/09553002.2013.804962. Epub 2013 Jun 12.

PMID:
23679232
5.

RF personal exposimetry on employees of elementary schools, kindergartens and day nurseries as a proxy for child exposures.

Juhász P, Bakos J, Nagy N, Jánossy G, Finta V, Thuróczy G.

Prog Biophys Mol Biol. 2011 Dec;107(3):449-55. doi: 10.1016/j.pbiomolbio.2011.09.020. Epub 2011 Oct 6.

PMID:
21986474
6.

Comprehensive & cost effective laboratory monitoring of HIV/AIDS: an African role model.

Lawrie D, Janossy G, Roos M, Glencross DK.

J Vis Exp. 2010 Oct 31;(44). pii: 2312. doi: 10.3791/2312.

PMID:
21085099
7.

Translational medicine as implementation science in the field of monitoring HIV and TB. New concepts emanating from resource-poor countries.

Janossy G, Mandy F.

Cytometry B Clin Cytom. 2010 May;78(3):183-7. doi: 10.1002/cyto.b.20527. No abstract available.

8.

From research tool to routine test: CD38 monitoring in HIV patients.

Coetzee LM, Tay SS, Lawrie D, Janossy G, Glencross DK.

Cytometry B Clin Cytom. 2009 Nov;76(6):375-84. doi: 10.1002/cyto.b.20478.

9.

Impaired antigen-specific CD4(+) T lymphocyte responses in cavitary tuberculosis.

Barry S, Breen R, Lipman M, Johnson M, Janossy G.

Tuberculosis (Edinb). 2009 Jan;89(1):48-53. doi: 10.1016/j.tube.2008.07.002. Epub 2008 Sep 16.

PMID:
18799355
10.

Local immunodiagnosis of pulmonary TB: ELISPOT or flow cytometry, PPD or ESAT-6?

Barry S, Lipman M, Breen R, Janossy G.

Eur Respir J. 2008 Aug;32(2):531-2; author reply 532-3. doi: 10.1183/09031936.00043908. No abstract available.

11.

Exposure to 50 Hz magnetic field in apartment buildings with built-in transformer stations in Hungary.

Thuróczy G, Jánossy G, Nagy N, Bakos J, Szabó J, Mezei G.

Radiat Prot Dosimetry. 2008;131(4):469-73. doi: 10.1093/rpd/ncn199. Epub 2008 Jul 30.

PMID:
18667401
12.

Long-term clinical and surrogate marker effects of subcutaneous intermittent interleukin-2 without antiretroviral therapy in HIV-infected patients.

Herzmann C, Cuthbertson Z, Fosdick L, Fisher M, Nelson M, Perry N, Law M, Wand H, Janossy G, Johnson MA, Youle M.

J Antimicrob Chemother. 2008 Sep;62(3):583-6. doi: 10.1093/jac/dkn238. Epub 2008 Jun 27.

PMID:
18587135
13.

Diagnostics in the shadow of HIV epidemics.

Janossy G, Mandy F, O'Gorman MR.

Cytometry B Clin Cytom. 2008;74 Suppl 1:S1-3. doi: 10.1002/cyto.b.20404.

14.

Affordable CD4 T-cell enumeration for resource-limited regions: a status report for 2008.

Mandy F, Janossy G, Bergeron M, Pilon R, Faucher S.

Cytometry B Clin Cytom. 2008;74 Suppl 1:S27-39. doi: 10.1002/cyto.b.20414. Review. Erratum in: Cytometry B Clin Cytom. 2009 Jan;76(1):63-5.

15.

CD8/CD38 activation yields important clinical information of effective antiretroviral therapy: findings from the first year of the CIPRA-SA cohort.

Glencross DK, Janossy G, Coetzee LM, Lawrie D, Scott LE, Sanne I, McIntyre JA, Stevens W.

Cytometry B Clin Cytom. 2008;74 Suppl 1:S131-40. doi: 10.1002/cyto.b.20391.

16.

Simplified cytometry for routine monitoring of infectious diseases.

Janossy G, Shapiro H.

Cytometry B Clin Cytom. 2008;74 Suppl 1:S6-10. doi: 10.1002/cyto.b.20405.

17.

Large-scale affordable PanLeucogated CD4+ testing with proactive internal and external quality assessment: in support of the South African national comprehensive care, treatment and management programme for HIV and AIDS.

Glencross DK, Janossy G, Coetzee LM, Lawrie D, Aggett HM, Scott LE, Sanne I, McIntyre JA, Stevens W.

Cytometry B Clin Cytom. 2008;74 Suppl 1:S40-51. doi: 10.1002/cyto.b.20384.

18.

Rapid diagnosis of smear-negative tuberculosis using immunology and microbiology with induced sputum in HIV-infected and uninfected individuals.

Breen RA, Hardy GA, Perrin FM, Lear S, Kinloch S, Smith CJ, Cropley I, Janossy G, Lipman MC.

PLoS One. 2007 Dec 19;2(12):e1335.

20.

The role of flow cytometry in the interferon-gamma-based diagnosis of active tuberculosis and its coinfection with HIV-1--A technically oriented review.

Janossy G, Barry SM, Breen RA, Hardy GA, Lipman M, Kern F.

Cytometry B Clin Cytom. 2008;74 Suppl 1:S141-51. Review.

21.

Clinical application of a rapid lung-orientated immunoassay in individuals with possible tuberculosis.

Breen RA, Barry SM, Smith CJ, Shorten RJ, Dilworth JP, Cropley I, McHugh TD, Gillespie SH, Janossy G, Lipman MC.

Thorax. 2008 Jan;63(1):67-71. Epub 2007 Aug 3.

PMID:
17675319
22.

Predictors of virological outcome and safety in primary HIV type 1-infected patients initiating quadruple antiretroviral therapy: QUEST GW PROB3005.

Hoen B, Cooper DA, Lampe FC, Perrin L, Clumeck N, Phillips AN, Goh LE, Lindback S, Sereni D, Gazzard B, Montaner J, Stellbrink HJ, Lazzarin A, Ponscarme D, Staszewski S, Mathiesen L, Smith D, Finlayson R, Weber R, Wegmann L, Janossy G, Kinloch-de Loes S; QUEST Study Group.

Clin Infect Dis. 2007 Aug 1;45(3):381-90. Epub 2007 Jun 26.

23.

Survey of residential 50 Hz EMF exposure from transformer stations.

Szabó J, Jánossy G, Thuróczy G.

Bioelectromagnetics. 2007 Jan;28(1):48-52.

PMID:
16988992
24.

A randomised trial of subcutaneous intermittent interleukin-2 without antiretroviral therapy in HIV-infected patients: the UK-Vanguard Study.

Youle M, Emery S, Fisher M, Nelson M, Fosdick L, Janossy G, Loveday C, Sullivan A, Herzmann C, Wand H, Davey RT Jr, Johnson MA, Tavel JA, Lane HC.

PLoS Clin Trials. 2006 May;1(1):e3. Epub 2006 May 19. Erratum in: PLoS Clin Trials. 2007 May;2(5):e23.

25.

Detection of mycobacterial antigen responses in lung but not blood in HIV-tuberculosis co-infected subjects.

Breen RA, Janossy G, Barry SM, Cropley I, Johnson MA, Lipman MC.

AIDS. 2006 Jun 12;20(9):1330-2.

PMID:
16816564
26.

Use of pulmonary interferon {gamma} responses to mycobacterial antigen to distinguish sarcoid associated optic neuropathy from tuberculosis.

Burton BJ, Breen RA, Janossy G, Acheson JF, Lipman MC.

Br J Ophthalmol. 2006 Jun;90(6):802-3. No abstract available.

27.

Local IFN-{gamma} responses in TB.

Breen RA, Hopkins S, Janossy G, Lipman MC, Cropley I.

Thorax. 2005 Sep;60(9):788-9. No abstract available.

28.

Multicentre evaluation of stable reference whole blood for enumeration of lymphocyte subsets by flow cytometry.

Edwards C, Belgrave D, Janossy G, Bradley NJ, Stebbings R, Gaines-Das R, Thorpe R, Sawle A, Arroz MJ, Brando B, Gratama JW, Orfao de Matos A, Papa S, Papamichail M, Lenkei R, Rothe G, Barnett D.

Cytometry B Clin Cytom. 2005 Jun 22. [Epub ahead of print]

29.

T lymphocytes among HIV-infected and -uninfected infants: CD4/CD8 ratio as a potential tool in diagnosis of infection in infants under the age of 2 years.

Zijenah LS, Katzenstein DA, Nathoo KJ, Rusakaniko S, Tobaiwa O, Gwanzura C, Bikoue A, Nhembe M, Matibe P, Janossy G.

J Transl Med. 2005 Feb 1;3(1):6.

30.

Dried blood spot technology for CD4+ T-cell counting.

Janossy G.

Lancet. 2004 Mar 27;363(9414):1074; author reply 1074-5. No abstract available.

PMID:
15051290
31.

Clinical flow cytometry, a hypothesis-driven discipline of modern cytomics.

Janossy G.

Cytometry A. 2004 Mar;58(1):87-97. Review. No abstract available.

32.
33.
34.

Stability of currently used cytometers facilitates the identification of pipetting errors and their volumetric operation: "time" can tell all.

Bergeron M, Lustyik G, Phaneuf S, Ding T, Nicholson JK, Janossy G, Shapiro H, Barnett D, Mandy F.

Cytometry B Clin Cytom. 2003 Mar;52(1):37-9. Review. No abstract available.

35.

Purified protein derivative-activated type 1 cytokine-producing CD4+ T lymphocytes in the lung: a characteristic feature of active pulmonary and nonpulmonary tuberculosis.

Barry SM, Lipman MC, Bannister B, Johnson MA, Janossy G.

J Infect Dis. 2003 Jan 15;187(2):243-50. Epub 2002 Dec 19.

PMID:
12552448
36.
37.

Affordable CD4(+)-T-cell counting by flow cytometry: CD45 gating for volumetric analysis.

Janossy G, Jani IV, Bradley NJ, Bikoue A, Pitfield T, Glencross DK.

Clin Diagn Lab Immunol. 2002 Sep;9(5):1085-94.

38.

Immune reconstitution pneumonitis following Pneumocystis carinii pneumonia in HIV-infected subjects.

Barry SM, Lipman MC, Deery AR, Johnson MA, Janossy G.

HIV Med. 2002 Jul;3(3):207-11.

39.

Stabilised cellular immuno-fluorescence assay: CD45 expression as a calibration standard for human leukocytes.

Bikoue A, Janossy G, Barnett D.

J Immunol Methods. 2002 Aug 1;266(1-2):19-32.

PMID:
12133619
40.

Precise CD4 T-cell counting using red diode laser excitation: for richer, for poorer.

Janossy G, Jani IV, Kahan M, Barnett D, Mandy F, Shapiro H.

Cytometry. 2002 Apr 15;50(2):78-85.

41.

CD45-assisted PanLeucogating for accurate, cost-effective dual-platform CD4+ T-cell enumeration.

Glencross D, Scott LE, Jani IV, Barnett D, Janossy G.

Cytometry. 2002 Apr 15;50(2):69-77.

42.

T-cell subset counting and the fight against AIDS: reflections over a 20-year struggle.

Mandy F, Nicholson J, Autran B, Janossy G.

Cytometry. 2002 Apr 15;50(2):39-45. Review.

43.

Multiplexed immunoassays by flow cytometry for diagnosis and surveillance of infectious diseases in resource-poor settings.

Jani IV, Janossy G, Brown DW, Mandy F.

Lancet Infect Dis. 2002 Apr;2(4):243-50. Review.

PMID:
11937424
44.

Parallel decline of CD8+/CD38++ T cells and viraemia in response to quadruple highly active antiretroviral therapy in primary HIV infection.

Tilling R, Kinloch S, Goh LE, Cooper D, Perrin L, Lampe F, Zaunders J, Hoen B, Tsoukas C, Andersson J, Janossy G; Quest Study Group.

AIDS. 2002 Mar 8;16(4):589-96.

PMID:
11873002
45.

Affordable CD4+ T cell counts by flow cytometry. II. The use of fixed whole blood in resource-poor settings.

Jani V, Janossy G, Iqbal A, Mhalu FS, Lyamuya EF, Biberfeld G, Glencross DK, Scott L, Reilly JT, Granger V, Barnett D.

J Immunol Methods. 2001 Nov 1;257(1-2):145-54.

PMID:
11687248
46.

Study protocol for the evaluation of the potential for durable viral suppression after quadruple HAART with or without HIV vaccination: the QUEST study.

Goh LE, Perrin L, Hoen B, Cooper D, Phillips A, Janossy G, Sonnenborg A, Tsoukas C, Lampe F, Kinloch S; QUEST Study Group.

HIV Clin Trials. 2001 Sep-Oct;2(5):438-44.

PMID:
11673819
47.

Affordable CD4(+) T-cell counts on 'single-platform' flow cytometers I. Primary CD4 gating.

Janossy G, Jani I, Göhde W.

Br J Haematol. 2000 Dec;111(4):1198-208.

PMID:
11167762
48.

Cytofluorometric methods for assessing absolute numbers of cell subsets in blood. European Working Group on Clinical Cell Analysis.

Brando B, Barnett D, Janossy G, Mandy F, Autran B, Rothe G, Scarpati B, D'Avanzo G, D'Hautcourt JL, Lenkei R, Schmitz G, Kunkl A, Chianese R, Papa S, Gratama JW.

Cytometry. 2000 Dec 15;42(6):327-46. Review.

49.

Cytopathology or immunopathology? The puzzle of cytomegalovirus pneumonitis revisited.

Barry SM, Johnson MA, Janossy G.

Bone Marrow Transplant. 2000 Sep;26(6):591-7. Review.

50.

Changes in CD4 lymphocyte counts after interruption of therapy in patients with viral failure on protease inhibitor-containing regimens. Royal Free Centre for HIV Medicine.

Youle M, Janossy G, Turnbull W, Tilling R, Loveday C, Mocroft A, Tyrer M, Madge S, Wilson D, Dykhoff A, Johnson M, Phillips AN.

AIDS. 2000 Aug 18;14(12):1717-20.

PMID:
10985307

Supplemental Content

Loading ...
Support Center